Showing 2 posts of 2 posts found.
Not a week goes by without a big pharma merger story, and now it’s the turn of Dublin-headquartered Shire that …
Shire is to acquire rare diseases firm NPS Pharma to enhance its profile following the collapse of its deal with …
AbbVie expands Oxford R&D facility with new £120m UK research commitment
MedPharm appoints Jason Mieding as chief operating officer
UKRI backs five hubs developing AI tools for earlier disease detection
Coriolis Pharma appoints Teun van der Heide as CEO
NEC joins €6.5m European project using AI for pandemic vaccine design